Electromed Reports Continued Growth Amid Leadership Transition
On August 25, Electromod (NASDAQ:ELMD) reported strong fiscal fourth-quarter results with net revenue reaching $19.4 million and diluted earnings per share rising to $0.39 from $0.25 a year ago. The company has now achieved fifteen consecutive quarters of year-over-year growth in both revenue and profit, driven primarily by its home care segment which saw 15.2% annual growth in the quarter. Despite these positive figures, there are underlying challenges including a significant decline in hospital business revenue (-29%) attributed to unpredictable sales cycles. Additionally, SG&A expenses increased by 8.7%, and operating cash flow declined slightly despite rising net income. The company is also undergoing leadership changes with CEO James Cunniff planning to retire in April 2027. Institutional interest has grown modestly but remains limited, while the stock trades at a forward P/E ratio of 7. Electromed continues to expand its market reach and payer agreements, enhancing e-prescribing capabilities ahead of regulatory changes by CMS.
Tickers: $ELMD